St. Louis, MO, United States of America

Christopher Pacia

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Washington University. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Pacia: Innovator in Noninvasive Brain Biopsy Technology

Introduction

Christopher Pacia is a notable inventor based in St. Louis, MO. He has made significant contributions to the field of medical technology, particularly in the area of brain diagnostics. His innovative approach focuses on noninvasive methods to assess brain conditions, which can greatly enhance patient care.

Latest Patents

Pacia holds a patent for "Methods and systems for noninvasive and localized brain liquid biopsy using focused ultrasound." This groundbreaking patent outlines techniques that allow for the identification of brain lesion or tumor characteristics without the need for a solid brain biopsy. The use of focused ultrasound represents a significant advancement in medical diagnostics, providing a safer and more efficient alternative for patients.

Career Highlights

Christopher Pacia is affiliated with Washington University, where he continues to develop and refine his innovative ideas. His work is at the intersection of technology and medicine, aiming to improve diagnostic processes and patient outcomes. With a focus on noninvasive techniques, he is paving the way for future advancements in brain health.

Collaborations

Pacia collaborates with esteemed colleagues such as Hong Chen and Eric Leuthardt. Their combined expertise contributes to the development of cutting-edge technologies in the medical field.

Conclusion

Christopher Pacia's contributions to noninvasive brain biopsy technology highlight his role as an innovator in the medical field. His work not only advances scientific understanding but also enhances patient care through safer diagnostic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…